We are Sorry, This Page doesn't Exist

The Food and Drug Administration has been in "sustained and ongoing" discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients "as quickly as possible, as appropriate," the agency said......»»

Pfizer Inc. (NYSE: PFE) chief executive officer Albert Bourla on Tuesday said the clinical trials for its novel coronavirus (COVID-19) vaccine are expected to start next week in the United States, pending approval from health regulators. read more.....»»

One of the key doctors leading the novel coronavirus (COVID-19) pandemic response at the federal level said he was fired from his job because he resisted the use of antimalarial drugs touted by President Donald Trump. read more.....»»

One of the local biotechs developing a vaccine for COVID-19 has announced its second chief executive change in the last week amid rumors that President Donald Trump attempted to negotiate exclusive rights to the company’s drug.  Control of Cure.....»»

Thomas Barrack, a confidant of President Donald Trump, is taking over as chief executive of Colony Capital, returning to the post he held before the real estate investment trust went public four years ago......»»

The agency's board also gave the greenlight to a team led by Related Beal and Dream Development to move forward with its proposal to build 402 apartments and condos on public land in Roxbury......»»

Democrats are less likely than their Republican counterparts to trust others regarding vaccination status, according to a new survey......»»

Moderna says its COVID-19 vaccine effective in kids as young as 12, will seek FDA approval.....»»

The U.S. Covid-19 vaccine rollout reached another milestone in early May when Pfizer Inc. and BioNTech SE, makers of the first inoculation authorized for emergency use in the country, asked for full regulatory approval. Such a designation for .....»»

BioNTech's chief executive has said that the COVID-1.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

The millions of Johnson & Johnson COVID-19 vaccine doses haven't been distributed to the public and are from a plagued Emergent BioSolutions facility. Employees wor.....»»

Emergent BioSolutions Inc. has made enough of a key ingredient to yield more than 100 million doses of Johnson & Johnson’s Covid-19 vaccine, and federal health regulators are evaluating whether to release the shots, Emergent’s chief executive said......»»

The FDA expanded emergency use of the Pfizer-BioNTech vaccine to children aged 12 to 15 on May 10, and so far no severe reactions have been reported. Charles Muro, age 13, celebrates being ino.....»»

Regulators have given the go-ahead for younger teens to begin getting Pfizer's COVID-19 shots, which has raised questions for some parents who want to better understand how a vaccine could affect their teenagers......»»

The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. read more.....»»

Indian COVID Strain Declared "Global Concern" As Data Show It's Vaccine-Resistant During the WHO's Monday press conference, Maria Van Kerkhove, the scientist in charge of the agency's COVID-19 response, declared that COVID-.....»»

A coronavirus pandemic linkfest is for now a weekly feature here on Abnormal Returns. Please stay safe and find a vaccination site... VaccinesPfizer ($PFE) is seeking full FDA approval of its Covid vaccine. (politico.com)Moderna ($MRNA) sol.....»»

Pfizer Inc. and German partner BioNTech SE said Friday.....»»